# Alkermes (stock symbol: ALKS) Logo in transparent PNG and SVG formats

## Alkermes Logo large

### Alkermes Logo large Download PNG (24.79 KB)

![Alkermes Logo large Download PNG (24.79 KB)](/img/orig/ALKS_BIG-902ee6e8.png)

### Alkermes Logo large Download SVG (5.72 KB)

![Alkermes Logo large Download SVG (5.72 KB)](/img/orig/ALKS_BIG-6a706457.svg)

## Alkermes Logo icon format

### Alkermes Logo icon format Download PNG (34.49 KB)

![Alkermes Logo icon format Download PNG (34.49 KB)](/img/orig/ALKS-ce7e18a6.png)

### Alkermes Logo icon format Download SVG (789 Bytes)

![Alkermes Logo icon format Download SVG (789 Bytes)](/img/orig/ALKS-c7ef320d.svg)

## Alkermes Logo large for dark backgrounds

### Alkermes Logo large for dark backgrounds Download PNG (24.79 KB)

![Alkermes Logo large for dark backgrounds Download PNG (24.79 KB)](/img/orig/ALKS_BIG.D-d46bf637.png)

### Alkermes Logo large for dark backgrounds Download SVG (5.72 KB)

![Alkermes Logo large for dark backgrounds Download SVG (5.72 KB)](/img/orig/ALKS_BIG.D-7d48462b.svg)

## Alkermes Logo icon format for dark backgrounds

### Alkermes Logo icon format for dark backgrounds Download PNG (34.49 KB)

![Alkermes Logo icon format for dark backgrounds Download PNG (34.49 KB)](/img/orig/ALKS.D-4a3fa672.png)

### Alkermes Logo icon format for dark backgrounds Download SVG (789 Bytes)

![Alkermes Logo icon format for dark backgrounds Download SVG (789 Bytes)](/img/orig/ALKS.D-bcbb1fd6.svg)

## About Alkermes

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

1. Website domain: alkermes.com
2. Employees: 2211
3. Marketcap: $4.74 Billion USD


## Categories
- [x] ðŸ‡®ðŸ‡ª Ireland
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
